VolulyteTM in Cardiac Surgery

NCT01553617 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart; Dysfunction Postoperative, Cardiac Surgery

Interventions

DRUG: 6% hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution (VolulyteTM)
DRUG: Human serum albumin

Sponsor

Fresenius Kabi